Core Viewpoint - The company, Xinyuren, which claims to be a leader in lithium battery intelligent equipment, is facing significant operational challenges despite its technological claims and partnerships with major players like CATL and BYD. The company's financial performance has deteriorated sharply, revealing a disconnect between its technological narrative and actual business performance [1][2]. Financial Performance - In 2024, Xinyuren reported a slight revenue increase of 4.75% to 622 million yuan, but net profit plummeted by 208.41% to a loss of 63.26 million yuan, with a non-recurring net loss of 79.27 million yuan [1][3][6]. - The gross margins for the company's main products, including lithium battery drying equipment and coating equipment, have decreased significantly, with reductions of 6.67, 7.56, and 13.47 percentage points respectively [3][5]. Business Operations - The company has three major projects funded by its IPO that have been delayed, with the intelligent equipment manufacturing project postponed from 2024 to 2026 [1][6]. - Xinyuren's reliance on a few major clients is concerning, with the largest client accounting for 61.24% of total sales and the top five clients representing 86.33% [9][10]. Market Environment - The lithium battery equipment market is experiencing structural overcapacity, leading to intensified price competition and a decline in industry profitability, with utilization rates below 50% [7][8]. - The industry is shifting from price competition to performance and technology competition, with leading companies like CATL and BYD advancing solid-state battery technologies, which may threaten Xinyuren's market position [8][9]. Future Outlook - The company faces increasing financial risks due to high accounts receivable and a significant rise in bad debt provisions, with operating cash flow negative for three consecutive years [6][9]. - The technological advancements of competitors and the potential in-house production capabilities of major clients pose additional threats to Xinyuren's business model [9][10].

Market Performance - The Sci-Tech Innovation Board (STAR Market) index rose by 0.19%, closing at 1007.53 points, with a total trading volume of 3.622 billion shares and a turnover of 124.775 billion yuan, resulting in an average turnover rate of 2.02% [1] - Among the tradable stocks on the STAR Market, 324 stocks closed higher, with 9 stocks experiencing a rise of over 10%, including Electric Wind Power, Fumiao Technology, and Shangwei New Materials, which hit the daily limit [1] - The distribution of turnover rates shows that 2 stocks had turnover rates exceeding 20%, 24 stocks had rates between 10% and 20%, and 59 stocks had rates between 5% and 10% [1] High Turnover Stocks - The stock with the highest turnover rate was Xinyuren, which closed up by 3.51% with a turnover rate of 23.24% and a transaction amount of 368 million yuan [3] - Other notable stocks included Aerospace Nanhu, which rose by 5.00% with a turnover rate of 20.06%, and Suochen Technology, which had a turnover rate of 19.66% [3] Sector Analysis - In terms of sector performance, the pharmaceutical and biotechnology sector had the most stocks with a turnover rate exceeding 5%, totaling 32 stocks, followed by the computer and electronics sectors with 18 and 7 stocks, respectively [2] - Among the high turnover stocks, 58 stocks rose today, with Fumiao Technology, Olin Biology, and DeMa Technology leading with increases of 20.02%, 18.93%, and 14.74%, respectively [2] Capital Flow - In terms of capital flow, 48 stocks with high turnover rates saw net inflows from main funds, with the highest net inflows recorded for Youkede, Kaiyin Technology, and Rongchang Biology, amounting to 104 million yuan, 9.403 million yuan, and 6.991 million yuan, respectively [2] - Conversely, the stocks with the largest net outflows included Guokexingong, Maiwei Biology, and Jiayuan Technology, with net outflows of 239 million yuan, 16.9 million yuan, and 13.4 million yuan, respectively [2] Leverage Fund Movements - A total of 51 stocks with high turnover rates recently received net purchases from leveraged funds, with notable increases in financing balances for Gaoce Shares, Shijia Photon, and Weixin Biology, which saw increases of 72.986 million yuan, 71.531 million yuan, and 71.373 million yuan, respectively [2]

Group 1 - The company held its 21st meeting of the 3rd Supervisory Board on July 4, 2025, in Huizhou, with all procedures complying with relevant laws and regulations [1] - The Supervisory Board unanimously approved the correction of accounting errors and the revision of periodic reports, ensuring that the financial data accurately reflects the company's financial status and operational results [1] - The meeting was attended by three supervisors, and the voting results showed 3 votes in favor, with no opposition or abstentions [2] Group 2 - The Supervisory Board agreed that using self-owned funds to pay for fundraising project expenses and replacing them with equivalent raised funds would enhance the efficiency of fund usage [2] - The implementation of this matter will not affect the normal progress of fundraising projects and does not violate any regulations regarding the use of raised funds [2] - The voting results for this proposal also showed 3 votes in favor, with no opposition or abstentions [2]

Core Viewpoint - The company, Shenzhen Xinyuren Technology Co., Ltd., is utilizing its own funds to pay for fundraising project expenses and will subsequently replace these with equivalent amounts from the raised funds, ensuring compliance with regulatory requirements and maintaining project efficiency [1][2][4]. Fundraising Overview - The company has successfully completed its initial public offering (IPO) of 24,438,597 shares at a price of RMB 23.68 per share, raising a total of approximately RMB 578.71 million. After deducting issuance costs of about RMB 72.51 million, the net proceeds amount to approximately RMB 506.20 million [1][2]. - The total investment for the fundraising projects is RMB 618.52 million, with RMB 462.25 million allocated from the raised funds [1]. Fund Utilization and Replacement Process - The company has opted to use its own funds for certain project expenses, particularly for land purchases, due to tax payment requirements that necessitate using a specific account not linked to the fundraising account. This approach allows for timely payments while ensuring that the raised funds are eventually used to reimburse these expenses [1][2]. - The process involves the company’s relevant departments preparing detailed payment records, followed by internal approvals, and then transferring equivalent amounts from the fundraising account to the company’s general account [2][4]. Impact on Company Operations - The decision to use self-funds for project expenses and later replace them with raised funds is expected to enhance the efficiency of fund utilization and project implementation, ensuring that the projects proceed smoothly without altering the intended use of the raised funds [4][5]. Approval and Oversight - The board of directors approved the use of self-funds for project expenses with a unanimous vote, and the supervisory board expressed agreement, confirming that this action does not affect the normal operation of the fundraising projects or violate any regulatory requirements [5][6]. - The sponsoring institution, Minsheng Securities, has conducted a review and found that the company has adhered to necessary procedures and regulations regarding the use of funds [6].

Overview - The company, Shenzhen Xinyuren Technology Co., Ltd., has announced corrections to its financial reports due to accounting errors related to revenue recognition and cash flow statements [1][4]. Accounting Errors and Corrections - The company identified an accounting error in revenue recognition for a transaction involving its subsidiary, Dongguan Jianxin Tianlan Technology Co., Ltd. The revenue was initially recognized using the gross method but was corrected to the net method, resulting in a revenue adjustment from RMB 68,141,592.93 to RMB 16,814,159.33 [2][3]. - The company also failed to offset internal cash flows of RMB 51,000,000.00 between the parent and subsidiary when preparing the consolidated cash flow statement for Q3 2024, leading to inaccuracies in cash flow reporting [3][4]. Financial Impact of Corrections - The adjustments affected various financial metrics, including accounts receivable, inventory, total assets, and net profit. For instance, the accounts receivable was adjusted from RMB 496,581,366.69 to RMB 435,617,966.69 [4][5]. - The net profit for the first half of 2024 was revised from RMB -32,868,195.23 to RMB -43,409,402.98, reflecting a significant impact on the company's financial performance [5][6]. Board and Committee Opinions - The Audit Committee and Board of Directors have reviewed and approved the corrections, confirming that the adjustments comply with relevant accounting standards and regulations [8][9]. - The company has committed to enhancing its internal control systems and financial management practices to prevent similar issues in the future [8][9].

深圳市信宇人科技股份有限公司2024 年年度报告 公司代码：688573 公司简称：信宇人 □是 √否 三、重大风险提示 锂电行业出现结构性产能过剩，导致市场价格竞争加剧，公司产品毛利率有所下降，导致公 司净利润有所下降。电池行业账期较长，导致应收账款占比较高，而下游行业不景气又使得客户 回款困难，进而使得应收账款坏账计提金额同比大幅增加，这些情况可能对公司的现金流状况产 生负面影响，导致公司财务风险上升。存货余额较高，市场竞争激烈导致部分产品价格在下半年 出现下降趋势，因此根据会计准则计提后，公司的存货跌价准备大幅上升，导致资产减值损失增 加。 深圳市信宇人科技股份有限公司 2024 年年度报告 1 / 243 深圳市信宇人科技股份有限公司2024 年年度报告 重要提示 一、本公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的真实性、准确性、 完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、公司上市时未盈利且尚未实现盈利 报告期内，不存在对公司生产经营产生实质性影响的特别重大风险。公司已在报告中详细描 述可能存在的相关风险，敬请查阅"第三节管理层讨论与分析：四、风 ...

证券代码：688573 证券简称：信宇人 公告编号：2025-029 深圳市信宇人科技股份有限公司 关于前期会计差错更正及定期报告更正的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 责任人还是代理人。企业在向客户转让商品前能够控制该商品的，该企业为主要 责任人，应当按照已收或应收对价总额确认收入；否则，该企业为代理人，应当 按照预期有权收取的佣金或手续费的金额确认收入，该金额应当按照已收或应收 对价总额扣除应支付给其他相关方的价款后的净额，或者按照既定的佣金金额或 比例等确定。"为了更严谨地执行收入准则，2024年公司对子公司东莞市见信天 蓝科技有限公司（以下简称"见信天蓝"）的一笔业务（以下简称"该笔业务"） 交易实质进行了更加严格的判断。鉴于见信天蓝对外销售的锂电池装配线系向外 部公司采购的成套设备，且见信天蓝在销售过程中并非作为"主要责任人"，基 于谨慎性考虑并结合审计机构相关建议，将该笔业务在半年报、季报的收入确认 方法由"总额法"调整为"净额法"。该笔业务原按总额法确认的收入金额为人 民币 ...

关于深圳市信宇人科技股份有限公司 2024 年年度报告的信息披露监管问询 函回复的核查意见 政旦志远核字第 250000300 号 政旦志远（深圳）会计师事务所（特殊普通合伙） Zandar Certified Public Accountants LLP 关于深圳市信宇人科技股份有限公司 2024 年年度报告的信息披露监管问询 函回复的核查意见 地 址：深圳市福田区鹏程一路广电金融中心11F 电 话：+86-755-88605026 www.zdcpa.com 关于深圳市信宇人科技股份有限公司 2024 年年度报告的信息披露监管问询函 回复的核查意见 政旦志远核字第 250000300 号 上海证券交易所： 《关于深圳市信宇人科技股份有限公司 2024 年年度报告的信息披露监管问 询函》（上证科创公函【2025】0247 号，以下简称"年报问询函"）奉悉。我们 已对年报问询函所提及的深圳市信宇人科技股份有限公司（以下简称"信宇人" 或"公司"）财务事项进行了审慎核查，现汇报如下： 问题 1、关于经营业绩。 （2024 年 1 月 1 日至 2024 年 12 月 31 日止） | | 目 | 录 | 页 次 ...

民生证券股份有限公司 关于深圳市信宇人科技股份有限公司 2024 年年度报告的信息披露监管问询函回复的核查意见 上海证券交易所： 根据贵所出具的《关于深圳市信宇人科技股份有限公司2024年年度报告的信息披露 监管问询函》（上证科创公函【2025】0247 号）（以下简称"年报问询函"）的要求， 民生证券股份有限公司（以下简称"持续督导机构"）作为深圳市信宇人科技股份有限 公司（以下简称"信宇人"或"公司"）首次公开发行股票并在科创板上市的保荐机 构，会同公司及相关中介机构，就年报问询函提及的事项逐项进行了认真讨论、核查与 落实，并出具了明确的核查意见如下： 1 问题1、关于经营业绩。 公司主要从事锂电池制造设备的研发、制造与销售，2024年公司实现营业收入6.22亿 元，同比增加4.75%；归母净利润-6326.40万元，扣非净利润-7926.87万元，为上市以来 首亏。2024年公司综合毛利率为19.61%，同比减少6.95个百分点。年报称，主要系行业结构 性产能过剩、市场竞争加剧、费用增加、应收账款及存货减值等因素，对公司业绩产生 影响。2025年一季度，公司归母净利润为-2586.53万元，仍处于亏损状 ...

民生证券股份有限公司 关于深圳市信宇人科技股份有限公司 使用自有资金支付募投项目所需资金并以募集资金等额置换 的核查意见 民生证券股份有限公司（以下简称"民生证券"或"保荐机构"）作为深圳 市信宇人科技股份有限公司（以下简称"信宇人"或"公司"）首次公开发行股 票并在科创板上市的保荐机构，根据《证券发行上市保荐业务管理办法》《上海 证券交易所科创板股票上市规则》《上市公司募集资金监管规则（2025 年 6 月 15 日起施行）》《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运 作》等有关规定，对公司使用自有资金支付募投项目所需资金并以募集资金等额 置换的事项进行了核查，具体情况如下： 一、募集资金基本情况 经中国证券监督管理委员会《关于同意深圳市信宇人科技股份有限公司首次 公开发行股票注册的批复》（证监许可[2023]1408 号）同意注册，公司首次公开 发行人民币普通股（A 股）股票 2,443.8597 万股，每股面值 1 元，每股发行价格 为人民币 23.68 元，募集资金总额为人民币 578,705,976.96 元，扣除各类发行费 用（不含增值税）人民币 72,505,761.61 元 ...